Ultra QQQ Proshares (QLD) 75.58 $QLD After Yesterday's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra QQQ Proshares (QLD) 75.58 $QLD

After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 19, 5:13PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $72.88 to a high of $74.33. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $73.47 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
QLD: 75.58 (+3.01)

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra QQQ After 1.13% Gain
Comtex SmarTrend(R) - Mon Oct 19, 5:12PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $72.88 to a high of $74.33. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $73.47 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
QLD: 75.58 (+3.01)

ProShares Ultra QQQ Set to Possibly Pullback After Yesterday's Rally of 1.13%
Comtex SmarTrend(R) - Mon Oct 19, 5:12PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $72.88 to a high of $74.33. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $73.47 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
QLD: 75.58 (+3.01)

ProShares Ultra QQQ Shares Down 8.2% Since SmarTrend's Sell Call (QLD)
Comtex SmarTrend(R) - Wed Oct 14, 10:12AM CDT
SmarTrend identified a Downtrend for ProShares Ultra QQQ (AMEX:QLD) on May 20th, 2015 at $77.11. In approximately 5 months, ProShares Ultra QQQ has returned 8.18% as of today's recent price of $70.80.
QLD: 75.58 (+3.01)

ProShares Ultra QQQ Falls 1.01% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Sep 29, 4:35PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $61.35 to a high of $64.51. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $62.53 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
QLD: 75.58 (+3.01)

Look for Shares of ProShares Ultra QQQ to Potentially Rebound after Yesterday's 1.01% Sell Off
Comtex SmarTrend(R) - Tue Sep 29, 4:34PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $61.35 to a high of $64.51. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $62.53 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
QLD: 75.58 (+3.01)

After Yesterday's Decline of 1.01%, ProShares Ultra QQQ Offers Investors Better Value
Comtex SmarTrend(R) - Tue Sep 29, 4:34PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $61.35 to a high of $64.51. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $62.53 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
QLD: 75.58 (+3.01)

Downtrend Call Working As ProShares Ultra QQQ Stock Falls 18.6% (QLD)
Comtex SmarTrend(R) - Tue Sep 29, 9:27AM CDT
SmarTrend identified a Downtrend for ProShares Ultra QQQ (AMEX:QLD) on May 20th, 2015 at $77.11. In approximately 4 months, ProShares Ultra QQQ has returned 18.57% as of today's recent price of $62.79.
QLD: 75.58 (+3.01)

10 Most Heavily Traded Leveraged ETFs YTD
Sweta Killa - Zacks Investment Research - Thu Sep 10, 10:15AM CDT
Leveraged ETFs have gained immense popularity in recent months owing to the high levels of volatility in the stock markets.
QLD: 75.58 (+3.01), UPRO: 64.02 (+3.19), UCO: 21.73 (-0.06), ERX: 35.25 (+1.83), SSO: 63.77 (+2.14), TNA: 68.35 (+2.19), UVXY: 27.74 (-5.76), UWTI: 9.79 (-0.04), FAS: 29.94 (+1.61), NUGT: 44.13 (+2.40)

BUYINS.NET: XBI, RPG, QQEW, QLD, COWN, ORIT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 08, 7:15AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Spdr S&P Biotech Etf (NYSE:XBI), Ram Power Corp (NYSE:RPG), First Trust Portfolios LP (NASDAQ:QQEW), ProShares Ultra QQQ (NYSE:QLD), Cowen Group Inc (NASDAQ:COWN), Oritani Financial Corp (NASDAQ:ORIT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
COWN: 4.18 (+0.07), QLD: 75.58 (+3.01), ORIT: 16.16 (+0.31), XBI: 64.33 (unch), QQEW: 43.35 (+0.95), RPG: 82.12 (+1.09)

ProShares Ultra QQQ Has Returned 22.9% Since SmarTrend Recommendation (QLD)
Comtex SmarTrend(R) - Mon Aug 24, 9:32AM CDT
SmarTrend identified a Downtrend for ProShares Ultra QQQ (AMEX:QLD) on May 20th, 2015 at $77.11. In approximately 3 months, ProShares Ultra QQQ has returned 22.87% as of today's recent price of $59.47.
QLD: 75.58 (+3.01)

ProShares Ultra QQQ Rises 1.66% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Aug 17, 4:53PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $76.78 to a high of $78.86. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $78.46 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
QLD: 75.58 (+3.01)

Watch for ProShares Ultra QQQ to Potentially Pullback After Gaining 1.52% Yesterday
Comtex SmarTrend(R) - Wed Aug 05, 4:58PM CDT
ProShares Ultra QQQ (AMEX:QLD) traded in a range yesterday that spanned from a low of $79.58 to a high of $81.13. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $80.43 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
QLD: 75.58 (+3.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Driven Tech Lands on 2026 CRN AI Innovators List

Updated Category News Views 4

New Milestone for Driven Tech in AI Innovation If there's one thing that's becoming crystal clear in the tech world, it's this: AI isn't just a flashy add-on anymore. Companies are diving deep into AI waters, transforming their business strategies from the ground up. Driven Tech, Inc., is doing just that, and their efforts haven't gone unnoticed—they’ve made it onto...

Continue Reading
Clarivate Taps Global Appetite for AI Research Tools

Updated Category News Views 8

A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...

Continue Reading
PKGD Group's Agave Spirits Surge 56% in 2026 Growth'

Updated Category News Views 1

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 3

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Rznomics Advances with EU Orphan Status for RZ-001

Updated Category News Views 3

RZ-001's European Success: A New Frontier Look, when a biopharmaceutical firm's RNA-editing therapy snags an Orphan Medicinal Product Designation from the European Commission, it's not just some clipboard milestone—it's a heavy-hitter move. That's exactly what Rznomics, the South Korean gene therapy player, pulled off with RZ-001. Now, we aren't just seeing paperwork...

Continue Reading
Durabook R12 Tablet: A Rugged Revolution for AI Tasks

Updated Category News Views 7

Edge AI Gets a Rugged Boost with Durabook's R12 In a world teeming with tech gadgets that crumble at the first sign of a challenge, Durabook's R12 Rugged Tablet makes a solid entrance. This ain't your everyday pretty gadget. Think of it as the big, burly bodyguard of tablets, ready to box through harsh environments without dropping a pixel. What’s stirring the pot this...

Continue Reading
When Families Should Consider Life Insurance Plans

Updated Category News Views 0

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Continue Reading
Hims & Hers Faces Class Action: Investor Implications

Updated Category News Views 6

Serious Scrutiny for Hims & Hers There's trouble in paradise, folks. Hims & Hers Health, Inc. (NYSE: HIMS) just landed in hot water, and it's not the soothing kind. We're talking about allegations of privacy violations and deceptive practices that have sent ripples—or more like waves—across the investor pond. If you're holding shares, you've probably felt the jolt...

Continue Reading
UMC and AP Memory Boost Power with New AI Chips

Updated Category News Views 4

Breaking Ground in Data Center Power Every so often, the tech industry gets a jolt of innovation that turns heads—not just for what it can do today, but for what it promises tomorrow. This time, it's United Microelectronics Corporation (UMC) and AP Memory shaking things up with their collaboration aimed at redefining power delivery for AI and high-performance computing...

Continue Reading
AuraQuantic Leads SPARK Matrix™ in 2026 IPO Ranking

Updated Category News Views 2

Not Just Another Day in Tech When tech outfits make headlines, it's often because of a shiny new gadget or some jarring security breach. Today, it's AuraQuantic getting their well-deserved spotlight, having snagged the leader's spot in the SPARK Matrix™ for Intelligent Process Orchestration (IPO). You might be wondering what makes this accolade worth attention in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Atlassian's Recent Options Activity Surge

Updated Category News Views 163

Analyzing Atlassian's Options Activity Recently, significant activity has been noted in the options market for Atlassian (NASDAQ: TEAM), suggesting fluctuating sentiment among investors. With several key trades occurring, it is vital to understand the underlying forces driving these changes. Insights from Options Trading An examination of options history indicates that a...

Continue Reading
Oncolytics Biotech's Strategic Move to Lead Cancer Innovation

Updated Category News Views 176

Oncolytics Biotech's Strategic Move to Lead Cancer Innovation In a time where the global oncology drug market is projected to exceed an astounding $900 billion, interest in cancer-focused biotechnology companies has surged significantly. Analysts highlight the increasing demand for innovative diagnostics and advanced immunotherapies driving this growth. Yet, as these...

Continue Reading
Transformations in Admirals Group AS Leadership and Governance

Updated Category News Views 170

Changes in Leadership at Admirals Group AS Admirals Group AS recently held a significant general meeting where key changes to its management and supervisory boards were decided. Effective from a stated future date, Anton Tikhomirov and Fedor Ragin have been appointed to the supervisory board for a term of five years. This shift marks an exciting new chapter in the...

Continue Reading
Athens Stock Market Reaches New Heights with Gains

Updated Category News Views 175

Athens Stock Market Performance Overview The latest updates reveal that Greece's stock market has closed on a positive note, showcasing notable increases across various sectors. The Athens General Composite Index has gained traction, finishing higher as key market sectors, particularly Construction, Travel, and Banking, experienced substantial growth. Sectorwise...

Continue Reading
Johnson & Johnson's Tremfya Shows Promising Results for Crohn's Disease

Updated Category News Views 227

Introduction to Tremfya and Crohn's Disease Tremfya, a medication developed by Johnson & Johnson, has gained notable attention for its role in treating Crohn's disease. Recently, new results from its Phase 3 GRAVITI study have sparked interest in its potential expanded usage, showing promising outcomes for patients. Exciting Results from the GRAVITI Study The GRAVITI...

Continue Reading